Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0001415889-22-008910

Options or other derivatives

  • Director acquired 66,468 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
GROOPMAN JEROME Director 2022-08-18 Grant or award · Stock Option (right to purchase) +66,468 66,468 D
Loading xslF345X03/form4-08192022_010815.xml…